Drugs / BI 11634
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02214953 | Oct → Dec 2007 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02214940 | Jun → Sep 2007 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02214927 | May → Jul 2007 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02214914 | Nov 2006 → Mar 2007 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 11634 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02214940 ↗ |
| Route | Oral | “Single Rising Oral Doses of BI 11634 Solution” NCT02214914 ↗ |